Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hypoglycemia

HCQ Prolongs QT Interval in Patients with COVID-19

Will Boggs, MD  |  May 5, 2020

NEW YORK (Reuters Health)—Potentially dangerous prolongation of the QT interval is common among patients hospitalized with COVID-19 who receive hydroxychloroquine (HCQ) with or without concomitant azithromycin, according to two new studies. “This is a well-known problem with HCQ and azithromycin, which became amplified in this higher risk population,” Christina F. Yen, MD, from Beth Israel…

Filed under:Drug Updates Tagged with:coronavirusCOVID-19Hydroxychloroquine (HCQ)

FDA Accelerates Approvals of Generic Versions of HCQ

U.S. Food and Drug Administration  |  April 8, 2020

On April 7, the FDA approved an Abbreviated New Drug Application (ANDA) for Hydroxychloroquine Sulfate Tablets USP, 200 mg, for the treatment of: 1) uncomplicated malaria due to P. falciparum, P. malariae, P. ovale and P. vivax; 2) chronic discoid lupus erythematosus and systemic lupus erythematosus in adults; and 3) treatment of acute and chronic…

Filed under:Uncategorized Tagged with:COVID-19FDAgeneric drugsHCQHydroxychloroquine (HCQ)U.S. Food and Drug Administration (FDA)

FDA Expands Label for Insulin Degludec; Adalimumab Biosimilar Moves Forward After Legal Battle

Michele B. Kaufman, PharmD, BCGP  |  April 18, 2018

The FDA has expanded the label for insulin degludec to include data on improved cardiovascular outcomes and deceased severe hypoglycemia…

Filed under:Drug Updates

A Defect in Mitochondrial Function May Underlie Chronic Fatigue Syndrome

Lara C. Pullen, PhD  |  January 1, 2018

The peripheral blood mononuclear cells (PBMCs) of patients with chronic fatigue syndrome (CFS) may be unable to meet certain energetic demands, according to a U.K. study. Researchers found that PBMCs in healthy individuals may adapt to environmental stressors by enhancing their ability to increase ATP production through mitochondrial respiration, but not in patients with CFS…

Filed under:Conditions Tagged with:chronic fatigue syndromeenvironmentalenvironmental factorMitochondrial Function

2015 ACR/ARHP Annual Meeting: How to Identify, Manage Metabolic Myopathies & Their Mimics

Thomas R. Collins  |  March 15, 2016

SAN FRANCISCO—An athletic 19-year-old male has an episode of rhabdomyolysis, a breakdown of muscle tissue that leads to contents of muscle fiber in the blood, after weight-lifting and basketball drills. But his labs come back normal. He cuts down on his exercise, but has a second episode four months later, then finally sees a rheumatologist…

Filed under:ConditionsMeeting ReportsMyositisSoft Tissue Pain Tagged with:2015 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)DiagnosismetabolicmuscleMyopathymyositispatient carerheumatologist

Can DIY Medicine Tame Rampaging Healthcare Costs?

Simon M. Helfgott, MD  |  April 1, 2015

High health insurance deductibles, physician charges, medication expenses spur patients to seek less costly lab testing, surgical procedures, prescription drugs

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:costsHealth InsuranceHelfgottMedicationprescription drugrheumatologysurgical procedure

Choosing Wisely: Recommendations from Medical Specialties Beyond Rheumatology

Kurt Ullman  |  October 1, 2014

Practice gems that may help rheumatologists avoid performing costly patient tests, procedures of limited use

Filed under:Drug UpdatesPractice SupportQuality Assurance/Improvement Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicscostsdrugimagingrheumatologistSafetyUllman

Metabolic Syndrome Linked to Higher Risk for Immunological Disorders

Lara C. Pullen, PhD  |  September 1, 2014

Research suggests patients with metabolic disorders, such as diabetes, might benefit from antiinflammatory drugs used to treat immunlogical disorders

Filed under:Biologics/DMARDsConditionsDrug UpdatesGout and Crystalline ArthritisResearch RheumRheumatoid Arthritis Tagged with:anti-inflammatoryBiologicsdiabetesdisorderdrugGoutmetabolicpatient carePullenRheumatoid arthritisrheumatologist

Reading Rheum

Daniel Hal Solomon, MD, MPH; Joan M. Von Feldt, MD;  |  November 1, 2007

Handpicked Reviews of Contemporary Literature

Filed under:ConditionsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Clinical researchHYDROXYCHLOROQUINELiteratureReading RheumRheumatoid Arthritis (RA)Steroidsystemic lupus erythematosus (SLE)

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences